Movement Alert｜IQVIA Rises 5.78% in Pre-Market Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings

Market Focus

Jul 23

On July 23, IQVIA rose 5.78% in pre-market trading, trading at $210.95/share, with turnover of $665,900. The stock rallied as multiple investment banks recently raised their price targets ahead of the company's Q2 earnings report scheduled for July 28.

In recent weeks, Leerink Partners raised its target from $213 to $240, Baird lifted its target to $252, Mizuho raised to $230, HSBC adjusted to $240, and Evercore ISI moved to $225, all maintaining outperform or equivalent ratings. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery forming core mid-term growth drivers. The company beat Q1 estimates with adjusted EPS of $2.90 versus the $2.82 consensus, reinforcing recovery momentum.

The broader Life Sciences Tools & Services sector traded higher on the same day, with Thermo Fisher Scientific up 6.22%, Danaher up 2.57%, Agilent up 2.11%, Repligen up 2.08%, and Waters up 1.94%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1129447808"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129447808\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129447808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 21:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129447808","market":"hk","top_or_hot":-1,"title":"Movement Alert｜IQVIA Rises 5.78% in Pre-Market Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings","media":"Market Focus","content":"<p><p>On July 23, IQVIA rose 5.78% in pre-market trading, trading at $210.95/share, with turnover of $665,900. The stock rallied as multiple investment banks recently raised their price targets ahead of the company's Q2 earnings report scheduled for July 28.</p><p>In recent weeks, Leerink Partners raised its target from $213 to $240, Baird lifted its target to $252, Mizuho raised to $230, HSBC adjusted to $240, and Evercore ISI moved to $225, all maintaining outperform or equivalent ratings. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery forming core mid-term growth drivers. The company beat Q1 estimates with adjusted EPS of $2.90 versus the $2.82 consensus, reinforcing recovery momentum.</p><p>The broader Life Sciences Tools & Services sector traded higher on the same day, with Thermo Fisher Scientific up 6.22%, Danaher up 2.57%, Agilent up 2.11%, Repligen up 2.08%, and Waters up 1.94%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜IQVIA Rises 5.78% in Pre-Market Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜IQVIA Rises 5.78% in Pre-Market Trading, Multiple Banks Raise Price Targets Ahead of Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-23 21:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 23, IQVIA rose 5.78% in pre-market trading, trading at $210.95/share, with turnover of $665,900. The stock rallied as multiple investment banks recently raised their price targets ahead of the company's Q2 earnings report scheduled for July 28.</p><p>In recent weeks, Leerink Partners raised its target from $213 to $240, Baird lifted its target to $252, Mizuho raised to $230, HSBC adjusted to $240, and Evercore ISI moved to $225, all maintaining outperform or equivalent ratings. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery forming core mid-term growth drivers. The company beat Q1 estimates with adjusted EPS of $2.90 versus the $2.82 consensus, reinforcing recovery momentum.</p><p>The broader Life Sciences Tools & Services sector traded higher on the same day, with Thermo Fisher Scientific up 6.22%, Danaher up 2.57%, Agilent up 2.11%, Repligen up 2.08%, and Waters up 1.94%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IQV","symbol_name":"艾昆纬","start_time":0,"source_url":"","article_id":"1129447808","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129447808","pubTimestamp":1784812280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 23, IQVIA rose 5.78% in pre-market trading, trading at $210.95/share, with turnover of $665,900. The stock rallied as multiple investment banks recently raised their price targets ahead of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IQV":"艾昆纬"},"translate_title":"走势警报|IQVIA 盘前交易上涨 5.78%，多家银行在第二季度财报公布前上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":1},"content_text":"On July 23, IQVIA rose 5.78% in pre-market trading, trading at $210.95/share, with turnover of $665,900. The stock rallied as multiple investment banks recently raised their price targets ahead of the company's Q2 earnings report scheduled for July 28.In recent weeks, Leerink Partners raised its target from $213 to $240, Baird lifted its target to $252, Mizuho raised to $230, HSBC adjusted to $240, and Evercore ISI moved to $225, all maintaining outperform or equivalent ratings. Management previously guided full-year revenue of $17.15 billion to $17.35 billion, with AI enablement and clinical trial recovery forming core mid-term growth drivers. The company beat Q1 estimates with adjusted EPS of $2.90 versus the $2.82 consensus, reinforcing recovery momentum.The broader Life Sciences Tools & Services sector traded higher on the same day, with Thermo Fisher Scientific up 6.22%, Danaher up 2.57%, Agilent up 2.11%, Repligen up 2.08%, and Waters up 1.94%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}